Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin vs Clindamycin for Odontogenic Maxillofacial Infections
NCT07810244Not yet recruiting
- Sponsor
- Nishtar Medical University
- Start
- Oct 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Randomised trial of moxifloxacin in odontogenic infection (OI) (2 arms), sponsored by Nishtar Medical University. Primary endpoints: Clinical Cure Rate and Pain Intensity. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
moxifloxacin
03
Conditions
odontogenic infection (OI)
Beyond the preview
Go deeper on NCT07810244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07810244.